← Leaderboards
Chih-Ming Ho
University Of California Los Angeles
$8,669,351
Attributed
$9,023,637
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2006–20$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,023,637 · 4
By mechanism
PN2$8,238,417 · 1
UH2$556,111 · 1
UH3$152,462 · 1
PN1$76,647 · 1
Top collaborators
- Ali Zarrinpar3 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Yazhen Zhu$5,188,074
- Hsian-Rong Tseng$15,333,457
- Vatche Agopian$3,720,225
- Alexandra Margaret Lynn Binder$4,845,425
- Derjung M Tarn$6,054,332
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseMalignant NeoplasmsIn VivoResponseHuman DiseasePhenotypeTechnologyBiologicalNanotechnologyComplexPathway InteractionsSignal PathwayEngineeringCellsFeedbackMonitorSignal TransductionEventGeneric DrugsElementsDetectionDevicesEnvironmentInvaded
Grant awards (14)
Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma$152,462
UH3 · FY2020 · TR
Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma$269,386
UH2 · FY2018 · TR
Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma$286,725
UH2 · FY2017 · TR
The Center for Systemic Control of Cyto-Networks$1,230,000
PN2 · FY2010 · EY · contact PI
The Center for Systemic Control of Cyto-Networks$2,816,967
PN2 · FY2009 · EY · contact PI
The Center for Systemic Control of Cyto-Networks$500,000
PN2 · FY2009 · EY · contact PI
The Center for Systemic Control of Cyto-Networks$1,220,000
PN2 · FY2008 · EY · contact PI
The Center for Systemic Control of Cyto-Networks$500,000
PN2 · FY2008 · EY · contact PI
The Center for Systemic Control of Cyto-Networks$902,000
PN2 · FY2007 · EY · contact PI
The Center for Systemic Control of Cyto-Networks$200,000
PN2 · FY2007 · EY · contact PI
The Center for Systemic Control of Cyto-Networks$154,000
PN2 · FY2007 · EY · contact PI
The Center for Systemic Control of Cyto-Networks$15,450
PN2 · FY2007 · EY · contact PI
The Center for Systemic Control of Cyto-Networks$700,000
PN2 · FY2006 · EY · contact PI
Nanotech Visualization/Reversible Apoptosis (RMI)$76,647
PN1 · FY2004 · EY